Disease specific productivity of american cancer hospitals

PloS One
Jeffery A Goldstein, Vinay Prasad

Abstract

Research-oriented cancer hospitals in the United States treat and study patients with a range of diseases. Measures of disease specific research productivity, and comparison to overall productivity, are currently lacking. Different institutions are specialized in research of particular diseases. To report disease specific productivity of American cancer hospitals, and propose a summary measure. We conducted a retrospective observational survey of the 50 highest ranked cancer hospitals in the 2013 US News and World Report rankings. We performed an automated search of PubMed and Clinicaltrials.gov for published reports and registrations of clinical trials (respectively) addressing specific cancers between 2008 and 2013. We calculated the summed impact factor for the publications. We generated a summary measure of productivity based on the number of Phase II clinical trials registered and the impact factor of Phase II clinical trials published for each institution and disease pair. We generated rankings based on this summary measure. We identified 6076 registered trials and 6516 published trials with a combined impact factor of 44280.4, involving 32 different diseases over the 50 institutions. Using a summary measure based on regi...Continue Reading

References

Apr 9, 1997·JAMA : the Journal of the American Medical Association·J GreenC Wells
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B E HillnerC E Desch
Sep 18, 2003·Journal of the National Cancer Institute·Elizabeth B LamontEverett E Vokes
Mar 5, 2004·Journal of the National Cancer Institute·Alvaro Muñoz, Jonathan Samet
Nov 4, 2004·JAMA : the Journal of the American Medical Association·Thomas G RobertsJeffrey W Clark
Mar 5, 2005·The New England Journal of Medicine·Elizabeth HorstmannChristine Grady
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert H El-Maraghi, Elizabeth A Eisenhauer
Nov 11, 2008·Health Affairs·Michael B RothbergPeter K Lindenauer
Feb 20, 2009·PLoS Medicine·Evelyne DecullierFrançois Chapuis
Apr 23, 2009·Molecular Oncology·Seth EckhouseRichard Sullivan
May 21, 2009·Medical Care Research and Review : MCRR·Tracy OnegaDavid C Goodman
Oct 13, 2009·Journal of Health Economics·Devin G Pope
Mar 26, 2010·Nature·Julia Lane
Apr 13, 2010·Journal of Neurosurgery·Francisco A Ponce, Andres M Lozano
Jun 11, 2011·Journal of the Royal Society of Medicine·Vanash M PatelThanos Athanasiou

❮ Previous
Next ❯

Software Mentioned

Scopus
BioEntrez
Web of Science
scipy
numpy
matplotlib
Google Scholar
Python
BioMedline
pandas

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.